Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options [Seeking Alpha]
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: Seeking Alpha
“We were pleased to successfully complete the appeal and have our shares relisted, and we are now firmly focused on moving forward,” said Chairman & CEO Dwight Egan. Egan said the Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Co-Diagnostics' strategies include expanding CoSara's laboratory presence and distribution in India and neighboring countries and executing the CoMira JV in MENA. Regulatory and clinical milestones, like CDCOS manufacturing licenses and sample accrual, govern the timelines for respiratory and TB test commercialization. The company faces continued operating losses, cash burn, and is exploring funding via equity, debt, strategic partnerships, and non-dilutive grants. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City [TheStreet.com]TheStreet.com
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial CityPR Newswire
- This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... [Yahoo! Finance]Yahoo! Finance
CODX
Earnings
- 3/31/26 - Miss
CODX
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- 3/10/26 - Form 8-K
- CODX's page on the SEC website